Literature DB >> 16207857

Medicare and cost-effectiveness analysis.

Peter J Neumann1, Allison B Rosen, Milton C Weinstein.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  2005        PMID： 16207857     DOI： 10.1056/NEJMsb050564

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  61 in total

Review 1.  The ethics and reality of rationing in medicine.

Authors:  Leslie P Scheunemann; Douglas B White
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  Comparative effectiveness: the employer perspective.

Authors:  Marc B Royo
Journal:  Biotechnol Healthc       Date:  2009-08

3.  Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease.

Authors:  H Fillit; J Cummings; P Neumann; T McLaughlin; P Salavtore; C Leibman
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

4.  Medicare, ethics, and reflexive longevity: governing time and treatment in an aging society.

Authors:  Sharon R Kaufman; Lakshmi Fjord
Journal:  Med Anthropol Q       Date:  2011-06

5.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

Review 6.  Information created to evade reality (ICER): things we should not look to for answers.

Authors:  Stephen Birch; Amiram Gafni
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 7.  Economic evaluation in the US: what is the missing link?

Authors:  Peter J Neumann; Sean D Sullivan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

8.  Healthcare technology and technology assessment.

Authors:  James H Herndon; Raymond Hwang; K J Bozic; K H Bozic
Journal:  Eur Spine J       Date:  2007-04-11       Impact factor: 3.134

9.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

Review 10.  When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology.

Authors:  Dan Greenberg; Craig Earle; Chi-Hui Fang; Adi Eldar-Lissai; Peter J Neumann
Journal:  J Natl Cancer Inst       Date:  2010-01-07       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.